These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32413092)

  • 1. Prolyl hydroxylase domain 2 reduction enhances skeletal muscle tissue regeneration after soft tissue trauma in mice.
    Settelmeier S; Schreiber T; Mäki J; Byts N; Koivunen P; Myllyharju J; Fandrey J; Winning S
    PLoS One; 2020; 15(5):e0233261. PubMed ID: 32413092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
    Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.
    Li L; Saliba P; Reischl S; Marti HH; Kunze R
    Neurobiol Dis; 2016 Jul; 91():221-35. PubMed ID: 27001147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional knockout of prolyl hydroxylase domain protein 2 attenuates high fat-diet-induced cardiac dysfunction in mice.
    Zeng H; Chen JX
    PLoS One; 2014; 9(12):e115974. PubMed ID: 25546437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
    HoWangYin KY; Loinard C; Bakker W; Guérin CL; Vilar J; d'Audigier C; Mauge L; Bruneval P; Emmerich J; Lévy BI; Pouysségur J; Smadja DM; Silvestre JS
    Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
    Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
    Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene.
    Wu S; Nishiyama N; Kano MR; Morishita Y; Miyazono K; Itaka K; Chung UI; Kataoka K
    Mol Ther; 2008 Jul; 16(7):1227-34. PubMed ID: 18500250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
    Guo Z; Yang Y; Li L; Zhao Q; Li Y; Liu Z; Hao L; Guo B; Diao A
    Eur J Pharmacol; 2022 Nov; 934():175307. PubMed ID: 36191632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
    An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
    J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
    Takeda K; Fong GH
    Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the hypoxia-inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice.
    Nunomiya A; Shin J; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Acta Physiol (Oxf); 2017 May; 220(1):99-112. PubMed ID: 27393382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal prolyl-4-hydroxylase 2 deficiency improves cognitive abilities in a murine model of cerebral hypoperfusion.
    Gruneberg D; Montellano FA; Plaschke K; Li L; Marti HH; Kunze R
    Exp Neurol; 2016 Dec; 286():93-106. PubMed ID: 27720797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway.
    Hodson EJ; Nicholls LG; Turner PJ; Llyr R; Fielding JW; Douglas G; Ratnayaka I; Robbins PA; Pugh CW; Buckler KJ; Ratcliffe PJ; Bishop T
    J Physiol; 2016 Mar; 594(5):1179-95. PubMed ID: 26337139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Regulates Chondrocyte Differentiation and Secondary Ossification in Mice.
    Cheng S; Aghajanian P; Pourteymoor S; Alarcon C; Mohan S
    Sci Rep; 2016 Oct; 6():35748. PubMed ID: 27775044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of Diabetic Wound Healing with PHD2- and miR-210-Targeting Oligonucleotides.
    Dallas A; Trotsyuk A; Ilves H; Bonham CA; Rodrigues M; Engel K; Barrera JA; Kosaric N; Stern-Buchbinder ZA; White A; Mandell KJ; Hammond PT; Mansbridge J; Jayasena S; Gurtner GC; Johnston BH
    Tissue Eng Part A; 2019 Jan; 25(1-2):44-54. PubMed ID: 29644938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2.
    Hulley PA; Bishop T; Vernet A; Schneider JE; Edwards JR; Athanasou NA; Knowles HJ
    J Pathol; 2017 Jul; 242(3):322-333. PubMed ID: 28418093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.